Primary Mucinous Adenocarcinoma of the Urethra: A Contemporary Clinicopathologic Analysis of 17 Patients.
Alaaeddin Alrohaibani,Adeboye O Osunkoya,Adeboye O. Osunkoya
DOI: https://doi.org/10.1016/j.prp.2024.155273
IF: 3.309
2024-03-31
Pathology - Research and Practice
Abstract:Mucinous adenocarcinoma of the urethra is rare. Here we performed a contemporary clinicopathologic analysis of this entity in both male and female patients. All cases with secondary tumors involving the urethra were excluded. Clinicopathologic parameters and follow up was obtained. Seventeen patients were included in the study, 9/17 (53%) male and 8/17 (47%) female. The mean patient age was 68 years (range: 53-88 years). The majority (11/17, 65%) of patients were African American, with an even greater incidence (7/8, 87%) in female patients. In male patients, prostatic urethra was the most common part of the urethra (6/9, 67%) where the tumor arose from. Immunohistochemical stains were performed in 11/17 (65%) tumors and were positive for CK20 (11/11, 100%), CDX2 (11/12, 92%), CK7 (8/9, 88%), GATA3 (3/8, 37%) and negative for NKX3.1, PSA, p63, PAX8, and Beta-Catenin. In resection specimens, tumors were categorized as pT2 (3/11, 27%), pT3 (1/11, 9%), and pT4 (7/11, 64%). Lymph node status was categorized as pN0 (6/9, 67%), pN1 (1/9, 11%), and pN2 (2/9, 22%). Available follow up data showed 5/9 (55%) patients developed recurrence after surgical resection and chemotherapy, of which 3/5 (60%) died of widespread metastatic disease. It is critical for pathologists and urologic oncologists to be aware of this entity in both male and female patients in view of potential diagnostic pitfalls, prognosis, and therapeutic implications.
pathology